[go: up one dir, main page]

ATE284205T1 - Magensaftresistente gelartige weichkapsel - Google Patents

Magensaftresistente gelartige weichkapsel

Info

Publication number
ATE284205T1
ATE284205T1 AT00992193T AT00992193T ATE284205T1 AT E284205 T1 ATE284205 T1 AT E284205T1 AT 00992193 T AT00992193 T AT 00992193T AT 00992193 T AT00992193 T AT 00992193T AT E284205 T1 ATE284205 T1 AT E284205T1
Authority
AT
Austria
Prior art keywords
present
soft capsule
resistant gel
juice resistant
pharmaceutical composition
Prior art date
Application number
AT00992193T
Other languages
English (en)
Inventor
Rao Pavuluri Mana Venkateswara
Podili Director-Te Khadgapathi
Original Assignee
Natco Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natco Pharma Ltd filed Critical Natco Pharma Ltd
Application granted granted Critical
Publication of ATE284205T1 publication Critical patent/ATE284205T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00992193T 1999-10-01 2000-08-25 Magensaftresistente gelartige weichkapsel ATE284205T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN968MA1999 1999-10-01
PCT/IN2000/000079 WO2001024780A2 (en) 1999-10-01 2000-08-25 Soft gel capsule resistant to gastric juices

Publications (1)

Publication Number Publication Date
ATE284205T1 true ATE284205T1 (de) 2004-12-15

Family

ID=11096707

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00992193T ATE284205T1 (de) 1999-10-01 2000-08-25 Magensaftresistente gelartige weichkapsel

Country Status (8)

Country Link
US (1) US20050095285A1 (de)
EP (1) EP1221947B1 (de)
JP (1) JP2003510348A (de)
AT (1) ATE284205T1 (de)
AU (1) AU2878801A (de)
CA (1) CA2386277A1 (de)
DE (1) DE60016617T2 (de)
WO (1) WO2001024780A2 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US20030235628A1 (en) * 2001-09-19 2003-12-25 Rajneesh Taneja Methods and pharmaceutical formulations for protecting pharmaceutical compounds from acidic environments
WO2004012701A2 (en) * 2002-08-02 2004-02-12 Scitech Centre NOVEL pH DEPENDENT ROBUST ENTERIC POLYMERIC CONTAINER, AN IMPROVEMENT OVER EXISTING ENTERIC DOSAGE FORMS.
CN1688294A (zh) * 2002-10-01 2005-10-26 旗帜药物胶囊公司 用于制备软胶囊壁的肠溶组合物
US9254270B2 (en) 2002-10-01 2016-02-09 Banner Life Sciences Llc Enteric soft capsules
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AU2003272081A1 (en) * 2003-09-25 2005-04-11 Natco Pharma Limited Enteric soft gelatin capsule containing esomeprazole and method of preparation
JP5096658B2 (ja) * 2003-10-06 2012-12-12 株式会社三協 生物学的利用能を向上させたソフトカプセル
GB0403247D0 (en) * 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
JP2009502841A (ja) * 2005-07-26 2009-01-29 グラクソ グループ リミテッド 脂質をベースにした製剤の腸溶性ポリマー中へのカプセル化
CN101610754A (zh) * 2007-02-16 2009-12-23 Aska制药株式会社 含有微粒油性混悬液的药物组合物
WO2009064814A2 (en) 2007-11-12 2009-05-22 Pharmaceutics International, Inc. Tri-molecular complexes and their use in drug delivery systems
EP2319504A1 (de) * 2009-11-07 2011-05-11 Laboratorios Del. Dr. Esteve, S.A. Feste pharmazeutische Dosierform
CN102125534B (zh) * 2010-01-20 2013-08-21 福州璐珈医药科技有限公司 一种泮托拉唑钠肠溶胶囊及其制备方法
JP5840668B2 (ja) * 2012-12-07 2016-01-06 富士カプセル株式会社 ロキソプロフェンナトリウム含有軟カプセル用内容物、及び、それを含有する軟カプセル製剤
US10660859B2 (en) * 2013-03-15 2020-05-26 Capsugel Belgium Nv Enteric coating for soft capsule
US10772842B2 (en) 2015-01-09 2020-09-15 Patheon Softgels Inc. Abuse-deterrent opioids
JP6190080B2 (ja) * 2014-05-20 2017-08-30 ダウ グローバル テクノロジーズ エルエルシー エステル化セルロースエーテルを含むカプセル殻
US9775814B2 (en) 2014-06-20 2017-10-03 Patheon Softgels Inc. Enteric soft capsule compositions
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
WO2017145146A1 (en) 2016-02-25 2017-08-31 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
EP3999013A4 (de) * 2019-07-15 2023-07-26 R.P. Scherer Technologies, LLC Weichgelkapsel mit enterischem protonenpumpeninhibitor
US20250288637A1 (en) * 2022-04-29 2025-09-18 Novatek Therapeutics, Llc Black seed oil formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3222476A1 (de) * 1982-06-15 1983-12-15 Warner-Lambert Co., 07950 Morris Plains, N.J. Magensaftresistente weichgelatinekapseln und verfahren zu ihrer herstellung
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
DE4322826A1 (de) * 1993-07-08 1995-01-12 Galenik Labor Freiburg Gmbh Pharmazeutisches Präparat
KR0131375B1 (ko) * 1993-10-19 1998-04-17 이승진 오메프라졸의 장용성 연질캅셀제제의 제조방법
AU7375598A (en) * 1997-05-09 1998-11-27 Sage Pharmaceuticals, Inc. Stable oral pharmaceutical dosage forms
US6531150B1 (en) * 1997-10-30 2003-03-11 Morishita Jintan Co., Ltd. Encapsulated unsaturated fatty acid substance and method for producing the same
ZA9810765B (en) * 1998-05-28 1999-08-06 Ranbaxy Lab Ltd Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole.
PT1191025E (pt) * 1999-06-30 2005-09-30 Takeda Pharmaceutical Cristais de lansoprazol
US6544556B1 (en) * 2000-09-11 2003-04-08 Andrx Corporation Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor

Also Published As

Publication number Publication date
EP1221947B1 (de) 2004-12-08
AU2878801A (en) 2001-05-10
JP2003510348A (ja) 2003-03-18
US20050095285A1 (en) 2005-05-05
DE60016617T2 (de) 2005-04-28
EP1221947A2 (de) 2002-07-17
WO2001024780A2 (en) 2001-04-12
WO2001024780A3 (en) 2001-10-04
DE60016617D1 (de) 2005-01-13
CA2386277A1 (en) 2001-04-12

Similar Documents

Publication Publication Date Title
ATE284205T1 (de) Magensaftresistente gelartige weichkapsel
PE105199A1 (es) Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion
MY102675A (en) Pharmaceutical formulations of acid labile substances for oral use.
ATE57614T1 (de) Ibuprofen enthaltende weichgelatinekapseln und verfahren zu ihrer herstellung.
NO160204C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkalisalter av 5-metoksy-2(((4-metoksy-3,5-dimetyl-2-pyridinyl)-metyl)-sulfinyl)-1h-benzimidazol.
FR2368270A1 (fr) Comprime destine au nettoyage des protheses dentaires ou d'autres appareils semblables, et procede de preparation de ce comprime
IT1164193B (it) Procedimento per l'immobilizzazione di materiali biologici in polimeri condensati di polialchilenimmine,composti contenenti un materiale biologico attivo e immobilizzato e procedimenti per la produzione di acido aspartico,di fenilanilina e di triptofano
HUT43589A (en) Process for production of derivatives of piramidine and medical compounds containing thereof as active substance
NL193107B (nl) N-£4-(3-aminopropyl)aminobutyl|-2-(omega-guanidinovetzuuramido -2-gesubstitueerde ethaanamide, zout daarvan en werkwijze ter bereiding daarvan.
IS3284A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
NO972128D0 (no) 2,2-dikloralkankarboksylsyrer, fremgangsmåte for fremstilling av disse, legemiddel inneholdende disse og anvendelse derav for behandling av insulinresistens
DK1009243T3 (da) Indföringssystem for mejerisyrevækkerkultur og anvendelse heraf
ES2110091T3 (es) Terapia tumoricida de efecto de alerta.
DE69503066D1 (de) KRISTALLFORM VON WASSERFREIEN 7-((1a,5a,6a)-6-AMINO-3-AZABICYCLO (3.1.0.) HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDIN-CARBONSÄURE METHANESULFONSÄURE SALZ
DE3484395D1 (de) Laser zur medizinischen behandlung kranker bereiche organischen gewebes.
DK1028714T3 (da) Vitaminsammensætning
IT7927440A0 (it) Enzima immobilizzato, procedimenti per la preparazione di detto enzima nonche' procedimento per effettuare una reazione enzimatica.
FR2535013B1 (fr) Appareil de deconnexion d'urgence de canalisations de chargement et de dechargement de fluide
BG106102A (en) Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations
ATE284678T1 (de) Acetaminophen mit verlängerter freisetzung
TR199900723T2 (xx) Y�ksek etkili madde a���a ��karan antimikotik jel.
FR2754824B1 (fr) Nouvelle composition contenant du chitosan
NO158096C (no) Fremgangsmaate for fremstilling av terapeutisk aktivt (z)-1,2-difenyl-l-(4-(2-(n,n-dimetylamino)etoksylfenyl)-l-buten (i) eller tamoxifen og syreaddisjonssalter derav.
MD1052G2 (ro) Metodă de imunoterapie Cuşnir
Hakim Isolation of a protease from the cell-free medium of in vitro cultured mammary carcinoma

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties